HELMEDIX
Helmedix Pty. Ltd. operates as a biopharmaceutical company which develops therapeutic peptide drugs for autoimmune diseases.
HELMEDIX
Industry:
Biotechnology Medical Therapeutics
Founded:
2012-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Total Employee:
1+
Status:
Active
Total Funding:
1.29 M USD
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Seed Round - Helmedix